<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00330759</url>
  </required_header>
  <id_info>
    <org_study_id>20050244</org_study_id>
    <nct_id>NCT00330759</nct_id>
  </id_info>
  <brief_title>Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.</brief_title>
  <official_title>A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amgen</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amgen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if denosumab is non-inferior to zoledronic acid
      (Zometa®) in the treatment of bone metastases (lytic bone lesions from multiple myeloma) in
      subjects with advanced cancer and multiple myeloma (excluding breast and prostate cancer)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to the First On-Study Skeletal-Related Event (Non-Inferiority)</measure>
    <time_frame>up to 33 months</time_frame>
    <description>Time to the first on-study skeletal-related event (SRE) using a non-inferiority analysis. Median was estimated using the Kaplan-Meier method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to First On-Study Skeletal-Related Event (Superiority)</measure>
    <time_frame>up to 33 months</time_frame>
    <description>Time to first on-study skeletal-related event (SRE) using a test for superiority. Median was estimated using the Kaplan-Meier method.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the First-and-Subsequent On-Study Skeletal-Related Event</measure>
    <time_frame>up to 33 months</time_frame>
    <description>Time to the first-and-subsequent on-study skeletal-related event (SRE) using multiple event analysis. To be considered a subsequent SRE, the event must occur at least 21 days after the previous SRE.
This outcome measure utilizes multiple event times, was analyzed based on a proportional mean model, and is therefore more appropriately summarized by the cumulative mean number of events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1779</enrollment>
  <condition>Bone Metastases</condition>
  <arm_group>
    <arm_group_label>zoledronic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>denosumab placebo with active zoledronic acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>denosumab</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>active denosumab with zoledronic acid placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Denosumab</intervention_name>
    <description>120 milligrams by subcutaneous injection every 4 weeks</description>
    <arm_group_label>denosumab</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Zoledronic Acid</intervention_name>
    <description>4 milligrams intravenous Zoledronic Acid over minimum 15 minutes every 4 weeks</description>
    <arm_group_label>zoledronic acid</arm_group_label>
    <other_name>Zometa</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with histologically/cystologically confirmed advanced cancers including solid
             tumors, multiple myeloma, and lymphoma

          -  Radiographic evidence of at least one bone metastasis (or lytic bone lesion from
             multiple myeloma); ECOG performance status 0, 1, or 2

          -  Adequate organ function

        Exclusion Criteria:

          -  Diagnosis of breast or prostate cancer

          -  Current or prior intravenous bisphosphonate administration

          -  Current or prior oral bisphosphonates for bone metastases, life expectancy of less
             than 6 months

          -  Prior history or current evidence of osteonecrosis/osteomyelitis of the jaw
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MD</last_name>
    <role>Study Director</role>
    <affiliation>Amgen</affiliation>
  </overall_official>
  <removed_countries>
    <country>Argentina</country>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Brazil</country>
    <country>Bulgaria</country>
    <country>Canada</country>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Latvia</country>
    <country>Lithuania</country>
    <country>Mexico</country>
    <country>Netherlands</country>
    <country>Peru</country>
    <country>Poland</country>
    <country>Portugal</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
    <country>South Africa</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>Ukraine</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </removed_countries>
  <link>
    <url>http://www.amgentrials.com</url>
    <description>AmgenTrials clinical trials website</description>
  </link>
  <reference>
    <citation>Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, Scagliotti GV, Sleeboom H, Spencer A, Vadhan-Raj S, von Moos R, Willenbacher W, Woll PJ, Wang J, Jiang Q, Jun S, Dansey R, Yeh H. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol. 2011 Mar 20;29(9):1125-32. doi: 10.1200/JCO.2010.31.3304. Epub 2011 Feb 22.</citation>
    <PMID>21343556</PMID>
  </reference>
  <reference>
    <citation>Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, García-Sáenz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A, Jacobs I. Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol. 2012 Dec;7(12):1823-9. doi: 10.1097/JTO.0b013e31826aec2b.</citation>
    <PMID>23154554</PMID>
  </reference>
  <reference>
    <citation>Vadhan-Raj S, von Moos R, Fallowfield LJ, Patrick DL, Goldwasser F, Cleeland CS, Henry DH, Novello S, Hungria V, Qian Y, Feng A, Yeh H, Chung K. Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Ann Oncol. 2012 Dec;23(12):3045-51. doi: 10.1093/annonc/mds175. Epub 2012 Jul 31.</citation>
    <PMID>22851406</PMID>
  </reference>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 25, 2006</study_first_submitted>
  <study_first_submitted_qc>May 25, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2006</study_first_posted>
  <results_first_submitted>December 9, 2010</results_first_submitted>
  <results_first_submitted_qc>March 4, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 9, 2014</results_first_posted>
  <disposition_first_submitted>June 29, 2010</disposition_first_submitted>
  <disposition_first_submitted_qc>June 29, 2010</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">July 1, 2010</disposition_first_posted>
  <last_update_submitted>July 14, 2014</last_update_submitted>
  <last_update_submitted_qc>July 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bone metastases</keyword>
  <keyword>lytic bone lesions</keyword>
  <keyword>advanced cancer</keyword>
  <keyword>multiple myeloma</keyword>
  <keyword>lymphoma</keyword>
  <keyword>solid tumors</keyword>
  <keyword>skeletal related events</keyword>
  <keyword>skeletal fractures</keyword>
  <keyword>spinal cord compressions, radiation to bone</keyword>
  <keyword>surgery to bone, bisphosphonates</keyword>
  <keyword>denosumab</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
    <mesh_term>Neoplasms, Plasma Cell</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Bone Neoplasms</mesh_term>
    <mesh_term>Bone Marrow Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zoledronic acid</mesh_term>
    <mesh_term>Diphosphonates</mesh_term>
    <mesh_term>Denosumab</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were enrolled from 21 June 2006 through 16 May 2008</recruitment_details>
      <pre_assignment_details>A total of 1779 participants were enrolled in the study. Three participants from one site were excluded from all analyses because Institutional Review Board (IRB) review activities and oversight were not ensured.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Zoledronic Acid</title>
          <description>Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks</description>
        </group>
        <group group_id="P2">
          <title>Denosumab</title>
          <description>Denosumab 120 mg by subcutaneous injection with an intravenous zoledronic acid placebo once every 4 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="890"/>
                <participants group_id="P2" count="886"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Received Investigational Product</title>
              <participants_list>
                <participants group_id="P1" count="878"/>
                <participants group_id="P2" count="878"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="178"/>
                <participants group_id="P2" count="180"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="712"/>
                <participants group_id="P2" count="706"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="316"/>
                <participants group_id="P2" count="310"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Disease progression</title>
              <participants_list>
                <participants group_id="P1" count="104"/>
                <participants group_id="P2" count="126"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="143"/>
                <participants group_id="P2" count="124"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Participant request</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Noncompliance</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol deviation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Ineligibility determined</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Zoledronic Acid</title>
          <description>Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks</description>
        </group>
        <group group_id="B2">
          <title>Denosumab</title>
          <description>Denosumab 120 mg by subcutaneous injection with an intravenous zoledronic acid placebo once every 4 weeks</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="890"/>
            <count group_id="B2" value="886"/>
            <count group_id="B3" value="1776"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.6" spread="10.7"/>
                    <measurement group_id="B2" value="59.3" spread="11.4"/>
                    <measurement group_id="B3" value="59.9" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="338"/>
                    <measurement group_id="B2" value="298"/>
                    <measurement group_id="B3" value="636"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="552"/>
                    <measurement group_id="B2" value="588"/>
                    <measurement group_id="B3" value="1140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White or Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="770"/>
                    <measurement group_id="B2" value="770"/>
                    <measurement group_id="B3" value="1540"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Japanese</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tumor Type Stratification Factor</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Multiple myeloma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="179"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="452"/>
                    <measurement group_id="B2" value="457"/>
                    <measurement group_id="B3" value="909"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-small cell lung cancer</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="345"/>
                    <measurement group_id="B2" value="343"/>
                    <measurement group_id="B3" value="688"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Previous Skeletal-Related Event Stratification Factor</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="446"/>
                    <measurement group_id="B2" value="440"/>
                    <measurement group_id="B3" value="886"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="444"/>
                    <measurement group_id="B2" value="446"/>
                    <measurement group_id="B3" value="890"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systematic Anti-Cancer Therapy Stratification Factor</title>
          <units>Participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="747"/>
                    <measurement group_id="B2" value="746"/>
                    <measurement group_id="B3" value="1493"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="143"/>
                    <measurement group_id="B2" value="140"/>
                    <measurement group_id="B3" value="283"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to the First On-Study Skeletal-Related Event (Non-Inferiority)</title>
        <description>Time to the first on-study skeletal-related event (SRE) using a non-inferiority analysis. Median was estimated using the Kaplan-Meier method.</description>
        <time_frame>up to 33 months</time_frame>
        <population>Full Analysis Set, composed of all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Zoledronic Acid</title>
            <description>Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>Denosumab</title>
            <description>Denosumab 120 mg by subcutaneous injection with an intravenous zoledronic acid placebo once every 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the First On-Study Skeletal-Related Event (Non-Inferiority)</title>
          <description>Time to the first on-study skeletal-related event (SRE) using a non-inferiority analysis. Median was estimated using the Kaplan-Meier method.</description>
          <population>Full Analysis Set, composed of all randomized participants.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="890"/>
                <count group_id="O2" value="886"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="496.0" lower_limit="371.00" upper_limit="589.00"/>
                    <measurement group_id="O2" value="625.0" lower_limit="456.00">Upper limit could not be estimated due to the low number of events</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>A synthesis approach was used for a non-inferiority test of the hypothesis that denosumab preserves at least 50% of the effect of zoledronic acid vs. placebo.</non_inferiority_desc>
            <p_value>0.0007</p_value>
            <method>Regression, Cox</method>
            <method_desc>Stratified by tumor type, previous skeletal-related event, and systematic anti-cancer therapy</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to First On-Study Skeletal-Related Event (Superiority)</title>
        <description>Time to first on-study skeletal-related event (SRE) using a test for superiority. Median was estimated using the Kaplan-Meier method.</description>
        <time_frame>up to 33 months</time_frame>
        <population>Full Analysis Set, composed of all randomized participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Zoledronic Acid</title>
            <description>Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>Denosumab</title>
            <description>Denosumab 120 mg by subcutaneous injection with an intravenous zoledronic acid placebo once every 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Time to First On-Study Skeletal-Related Event (Superiority)</title>
          <description>Time to first on-study skeletal-related event (SRE) using a test for superiority. Median was estimated using the Kaplan-Meier method.</description>
          <population>Full Analysis Set, composed of all randomized participants.</population>
          <units>Days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="890"/>
                <count group_id="O2" value="886"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="496.0" lower_limit="371.00" upper_limit="589.00"/>
                    <measurement group_id="O2" value="625.0" lower_limit="456.00">Upper limit could not be estimated due to the low number of events.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.060</p_value>
            <method>Regression, Cox</method>
            <method_desc>P-value was adjusted for multiplicity according to a hierarchical testing strategy and Hochberg procedure.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.84</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>0.98</ci_upper_limit>
            <estimate_desc>Stratified by tumor type, previous skeletal-related event, and systematic anti-cancer therapy</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to the First-and-Subsequent On-Study Skeletal-Related Event</title>
        <description>Time to the first-and-subsequent on-study skeletal-related event (SRE) using multiple event analysis. To be considered a subsequent SRE, the event must occur at least 21 days after the previous SRE.
This outcome measure utilizes multiple event times, was analyzed based on a proportional mean model, and is therefore more appropriately summarized by the cumulative mean number of events.</description>
        <time_frame>up to 33 months</time_frame>
        <population>Full Analysis Set, composed of all randomized participants</population>
        <group_list>
          <group group_id="O1">
            <title>Zoledronic Acid</title>
            <description>Zoledronic acid 4 mg by intravenous injection with a subcutaneous denosumab placebo once every 4 weeks</description>
          </group>
          <group group_id="O2">
            <title>Denosumab</title>
            <description>Denosumab 120 mg by subcutaneous injection with an intravenous zoledronic acid placebo once every 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the First-and-Subsequent On-Study Skeletal-Related Event</title>
          <description>Time to the first-and-subsequent on-study skeletal-related event (SRE) using multiple event analysis. To be considered a subsequent SRE, the event must occur at least 21 days after the previous SRE.
This outcome measure utilizes multiple event times, was analyzed based on a proportional mean model, and is therefore more appropriately summarized by the cumulative mean number of events.</description>
          <population>Full Analysis Set, composed of all randomized participants</population>
          <units>Events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="890"/>
                <count group_id="O2" value="886"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="436"/>
                    <measurement group_id="O2" value="392"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.145</p_value>
            <method>Anderson-Gill model</method>
            <method_desc>P-value was adjusted for multiplicity according to a hierarchical testing strategy and Hochberg procedure.</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.90</param_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>0.77</ci_lower_limit>
            <ci_upper_limit>1.04</ci_upper_limit>
            <estimate_desc>Stratified by tumor type, previous skeletal-related event, and systematic anti-cancer therapy</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to 2 years 9 months</time_frame>
      <desc>The table of Other Adverse Events summarizes the most frequent non-serious occurrences of adverse events.</desc>
      <group_list>
        <group group_id="E1">
          <title>Zoledronic Acid 4 mg Q4W</title>
        </group>
        <group group_id="E2">
          <title>Denosumab 120 mg Q4W</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="581" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="552" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Agranulocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Anaemia of chronic disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Aplastic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bone marrow failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Disseminated intravascular coagulation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Erythropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Febrile bone marrow aplasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Febrile neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Granulocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hyperviscosity syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Retroperitoneal lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Arrhythmia supraventricular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiac disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiogenic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary failure</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Congestive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Paroxysmal arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pericarditis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sinus tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Ventricular fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Goitre</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypopituitarism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Retinal vein occlusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Visual acuity reduced</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Aphagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Caecitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Colonic obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Enterocolitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Enterovesical fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Faecal incontinence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastrointestinal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hypomotility</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Intestinal perforation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Intra-abdominal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mechanical ileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neutropenic colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Obstruction gastric</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peritoneal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumoperitoneum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Retching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sigmoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Subileus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse event</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Catheter related complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Disease progression</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Euthanasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Generalised oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hyperpyrexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Inflammation of wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mucosal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Organ failure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Performance status decreased</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Suprapubic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Systemic inflammatory response syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cholestasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hepatorenal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hepatorenal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Liver disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Drug hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Abdominal wall infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Aspergillosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Brain abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Catheter related infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cavernous sinus thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Clostridial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Empyema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Febrile infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastritis fungal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Gastrointestinal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Kidney infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lower respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lung abscess</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mastoiditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neutropenic infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neutropenic sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Parotitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Perirectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peritonitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumocystis jiroveci pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumonia haemophilus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pseudomembranous colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pulmonary mycosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pulmonary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Purulent discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pyothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Salmonellosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Viral pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Collapse of lung</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Drug toxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Fractured ischium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Ilium fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lung injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Post procedural discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Radiation oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Splenic rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Subdural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Therapeutic agent toxicity</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tibia fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Blood calcium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Blood creatinine abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Blood potassium</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Blood potassium decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Creatinine renal clearance decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Monoclonal immunoglobulin present</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Platelet count increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sputum abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>White blood cell count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cachexia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="34" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypomagnesaemia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypophosphataemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Marasmus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Vitamin D deficiency</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Coccydynia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Joint crepitation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mobility decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Osteitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Osteolysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pain in jaw</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pathological fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Polyarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bile duct cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cancer pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cervix cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Colon cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hepatic cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Malignant ascites</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Malignant neoplasm progression</sub_title>
                <counts group_id="E1" subjects_affected="100" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="103" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Malignant pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to abdominal cavity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to bone</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to bone marrow</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to gastrointestinal tract</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to liver</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to lung</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to lymph nodes</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to meninges</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to peritoneum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to pleura</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to rectum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastases to spine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastasis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastatic bronchial carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastatic carcinoma of the bladder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastatic malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastatic pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Paraneoplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pericardial effusion malignant</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pharyngeal neoplasm benign</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Rectal cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Rectal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sarcoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tumour associated fever</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tumour pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tumour thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Apraxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Ataxia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Brain oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cauda equina syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cerebral artery embolism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cerebral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cervical cord compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cervical root pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cognitive disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Coma</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Coma uraemic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diplegia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dyskinesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Epiduritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Epilepsy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Facial paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hemiplegia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Intracranial pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mental impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Monoparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Monoplegia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Motor dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Nerve root compression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neurological decompensation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neurotoxicity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Paraparesis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Paraplegia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peripheral motor neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peripheral sensory neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Polyneuropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Polyneuropathy alcoholic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Psychomotor skills impaired</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sensory disturbance</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Sensory loss</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Speech disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Spinal cord compression</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Completed suicide</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Emotional distress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Psychotic disorder due to a general medical condition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Anuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Azotaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bladder mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bladder obstruction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bladder pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Chromaturia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Nephroangiosclerosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oliguria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urethral obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urethral stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Urinary tract disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dysfunctional uterine bleeding</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Orchitis noninfective</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Uterine haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Aspiration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bronchial obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bronchitis chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="54" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="55" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dyspnoea at rest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Emphysema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hydrothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lung disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oesophagobronchial fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pharyngeal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pulmonary haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Respiratory arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Respiratory tract congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Respiratory tract haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tachypnoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tracheal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lichenoid keratosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Panniculitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Petechiae</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Skin lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Stevens-Johnson syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Immobile</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Abdominal wall operation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Medical device removal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Tooth extraction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Aortic occlusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Arterial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Arteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypovolaemic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Jugular vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Lymphoedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peripheral arterial occlusive disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Phlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Subclavian vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Superior vena caval occlusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Vena cava thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Venous thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Venous thrombosis limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="767" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="751" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="264" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="234" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="68" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="50" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="100" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="90" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="84" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="209" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="188" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="165" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="163" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="260" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="244" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="167" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="174" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="171" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="156" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="85" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="216" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="203" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Mucosal inflammation</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="43" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="135" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="106" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="47" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="170" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="125" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="39" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Thoracic vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="105" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="99" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Anorexia</sub_title>
                <counts group_id="E1" subjects_affected="190" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="163" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="45" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="88" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="63" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="137" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="124" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="183" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="169" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Bone pain</sub_title>
                <counts group_id="E1" subjects_affected="149" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="137" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="95" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="92" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="128" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="121" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="67" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="93" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="99" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Neuropathy peripheral</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="45" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="73" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="56" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="93" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="89" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="151" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="172" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="171" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="193" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="62" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="878"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="878"/>
                <counts group_id="E2" subjects_affected="67" subjects_at_risk="878"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Clinical Trial Agreement generally does not restrict an investigator's discussion of trial results aftercompletion. The Agreement permits Amgen a limited period of time to review material discussing trial results (typically up to 45 days and possible extension). Amgen may remove confidential information, but authors have final control and approval of publication content. For multicenter studies, the investigator agrees not to publish any results before the first multi-center publication.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Study Director</name_or_title>
      <organization>Amgen Inc.</organization>
      <phone>866-572-6436</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

